Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05729256 · ClinicalTrials.gov registry record · NA
Alcohol and "Heat of the Moment" Sexual Decision Making
A NA study of HIV and Alcohol Drinking, sponsored by Boston University Charles River Campus.
- Recruiting
- Registry status
- NA
- Development phase
- 354
- Enrollment target
- 1
- Study location
NCT05729256: Recruiting NA study of HIV and Alcohol Drinking, sponsored by Boston University Charles River Campus.
NCT05729256 is a NA study of HIV and Alcohol Drinking that is actively recruiting participants, run by Boston University Charles River Campus. The registered enrollment target is 354 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05729256, a NA study of HIV and Alcohol Drinking, is actively recruiting participants, sponsored by Boston University Charles River Campus.
- RECRUITING
- Registry status
- NA
- Development phase
- 354 participants
- Enrollment target
- 1
- Study location
Study Summary
HIV transmission remains a significant public health concern, especially among men who have sex with men (MSM). Condomless anal intercourse (CAI) continues to be the major route of transmission for MSM. Thus, to reduce the incidence of HIV, it is critical to identify how contextual risk factors influence CAI and develop behavioral strategies that modify risk factors directly or reduce their influence on behavior. This study will examine the mechanisms through which one of the central contextual risk factors, heavy drinking, influences sexual decision processes in the natural environment and test the benefit of a brief intervention designed to reduce sexual risk behavior among those who engage in heavy drinking.
Primary Outcome
Self-reported number of times engaged in CAI
Conditions Studied
Interventions
- BEHAVIORAL Self-Regulation Intervention
- BEHAVIORAL Brief Advice and Information
Study Locations (1)
Massachusetts
- Boston University Department of Psychological and Brain Sciences - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 354 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2026-11 |
| Phase | NA |
What NCT05729256 shows while recruiting
NCT05729256 is an interventional study that assigns participants to a tested intervention. The registered 354 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (19% lower).
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Self-Regulation Intervention is the first listed.
NCT05729256 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05729256 about?
NCT05729256 is a clinical study titled "Alcohol and "Heat of the Moment" Sexual Decision Making". HIV transmission remains a significant public health concern, especially among men who have sex with men (MSM). Condomless anal intercourse (CAI) continues to be the major route of transmission for MSM. Thus, to reduce the incidence of HIV, it is critical to identify how contextual risk factors infl...
What is the current status of trial NCT05729256?
This trial is currently recruiting. It is a NA study. The enrollment target is 354 participants. The study started on 2023-11-01. Estimated completion is 2026-11.
What conditions does trial NCT05729256 study?
This clinical trial studies the following conditions: HIV, Alcohol Drinking, Sex, Unsafe.
What interventions are being tested in trial NCT05729256?
The interventions under investigation include: Self-Regulation Intervention (BEHAVIORAL), Brief Advice and Information (BEHAVIORAL).
Who is sponsoring clinical trial NCT05729256?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05729256 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05729256's enrollment target sits among peer trials
354 57th of 303 higher than 246 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02579967 · 354 participants · Phase 2
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- NCT02610413 · 354 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
- NCT06507618 · 354 participants · Phase 3
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
- NCT07133308 · 355 participants · Phase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI